Skip to main content

Day: March 26, 2024

Aecon consortium selected to redevelop the Cyril E. King Airport and Henry E. Rohlsen Airport in the U.S. Virgin Islands

TORONTO, March 26, 2024 (GLOBE NEWSWIRE) — Aecon Group Inc. (TSX: ARE) (“Aecon”) announced today that VIports Partners (“VIports”), an Aecon-led consortium, has been selected by the U.S. Virgin Islands Port Authority (“VIPA”) to redevelop the Cyril E. King Airport in St. Thomas and the Henry E. Rohlsen Airport in St. Croix under a collaborative Design, Build, Finance, Operate and Maintain (“DBFOM”) Public-Private Partnership model. VIports is comprised of Aecon, Tikehau Star Infra, Consigli Benton Joint Venture (J. Benton Construction) and Avports. Aecon Concessions will hold a 50% equity interest in the 40-year concession with Tikehau Star Infra also holding 50% of the equity. Aecon, as Design-Build lead, will also have a 50% interest in the Design-Build joint venture together with local partner J. Benton Construction. Avports...

Continue reading

Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.22 per Share for Q1 2024

HOUSTON, March 26, 2024 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) announced today a quarterly distribution of $0.22 per share for the fiscal quarter ended February 29, 2024. This distribution is payable to common stockholders on April 12, 2024 (as outlined in the table below).Ex-Date Record Date Payment Date Distribution Amount Return of Capital Estimate14/4/24 4/5/24 4/12/24 $0.22 40%1This estimate is based on the Company’s anticipated earnings and profits. The final determination of the tax character of distributions will not be determinable until after the end of fiscal 2024 and may differ substantially from this preliminary information. Kayne Anderson Energy Infrastructure Fund, Inc. (NYSE: KYN) is a non-diversified, closed-end management investment company registered...

Continue reading

SFL – Notice of Annual General Meeting 2024

SFL Corporation Ltd. (NYSE: SFL) (“SFL” or the “Company”) advises that the 2024 Annual General Meeting of the Company will be held on April 29, 2024. The record date for voting at the Annual General Meeting is set to April 2, 2024. A copy of the Notice of Annual General Meeting and associated information, including the Company’s Annual Report on Form 20-F, will be distributed and made available on the Company’s website at www.sflcorp.com prior to the meeting. March 26, 2024 The Board of DirectorsSFL Corporation Ltd.Hamilton, Bermuda About SFL SFL has a unique track record in the maritime industry and has paid dividends every quarter since its initial listing on the New York Stock Exchange in 2004. The Company’s fleet of vessels is comprised of tanker vessels, bulkers, container vessels, car carriers and offshore drilling rigs. SFL’s long...

Continue reading

Trisura Closes the Acquisition of First Founders

TORONTO, March 26, 2024 (GLOBE NEWSWIRE) — Trisura Group Ltd. (“Trisura” or “Trisura Group”) (TSX: TSU), a leading specialty insurance provider, today announced the closing of the acquisition of First Founders Assurance Company (“FFAC”), a U.S. Treasury listed surety company. This acquisition further demonstrates Trisura’s commitment to the U.S. surety market and is an important step in achieving our long-term growth plans. An immediate effort is underway to broaden FFAC’s licenses to include all 50 states and the District of Columbia.   “The acquisition of First Founders is an exciting step for Trisura and our North American surety capabilities as we further develop our US infrastructure. As we expand licenses, the Treasury listed entity will allow Trisura to access a broader portion of a larger surety market,” commented David...

Continue reading

Wilhelmina International, Inc. Announces Fourth Quarter and Full Year 2023 Results

Annual Financial HighlightsAnnual revenues of $17.2 million for 2023. Annual operating income of $0.7 million in 2023. Annual net cash flows provided by operating activities were $0.7 million in 2023. Annual pre-tax income of $0.7 million, net income of $0.4 million and Pre-Corporate EBITDA of $2.0 million for 2023. $12.7 million of combined cash and cash equivalents and short term investments at December 31, 2023 was the highest total at the end of any quarterly or annual period in Company history. Annual gross billings of $65.9 million for 2023. (in thousands) Q4 23 Q4 22 YOYChange Year Ended2023 Year Ended2022 YOYChangeTotal Revenues $3,763 $4,091 (8.0%) $17,212 $17,780 (3.2%)Operating (Loss) Income (117) (166) (29.5%) $728 2,419 (69.9%)Income (Loss) Before Provision for Taxes (92) (214) (57.0%) 691 2,575 (73.2%)Net...

Continue reading

Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update

CHASKA, Minn., March 26, 2024 (GLOBE NEWSWIRE) —  Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), announced today that Ernst & Young LLP, the Company’s independent registered public accounting firm for the fiscal year ended May 28, 2023, determined that it declined to stand for reappointment as the Company’s independent registered public accounting firm for the Company’s fiscal year ending May 26, 2024 following the filing of the Company’s Annual Report on Form 10-K. Lifecore’s board of directors has initiated a search for a replacement. In addition, the Company expects to provide a business update on Monday, April 1, 2024, which is expected to include certain select financial data for fiscal year 2024 and an update on...

Continue reading

Zevra Therapeutics Announces Top-Line Data from the Phase 2 Clinical Trial of KP1077 for Idiopathic Hypersomnia

KP1077 demonstrates clinically meaningful benefits for key IH symptoms Top-line data provide key information for the design of a Phase 3 study CELEBRATION, Fla., March 26, 2024 (GLOBE NEWSWIRE) — Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company) a rare disease therapeutics company, today announced top-line data from its placebo-controlled, double-blind Phase 2 clinical trial (NCT05668754) evaluating the safety and tolerability of KP1077 (serdexmethylphenidate, or SDX) in patients with idiopathic hypersomnia (IH). This proof-of-concept study was not powered to demonstrate statistical significance.   The data gathered for several secondary and exploratory endpoints, including the Epworth Sleepiness Scale (ESS), Idiopathic Hypersomnia Severity Scale (IHSS) and Sleep Inertia Visual Analog Scale (SIVAS) will inform the...

Continue reading

U.S. Energy Corp. Reports Financial and Operating Results for Full Year and Fourth Quarter 2023

HOUSTON, March 26, 2024 (GLOBE NEWSWIRE) — U.S. Energy Corporation (NASDAQ: USEG, “U.S. Energy” or the “Company”), a growth-focused energy company engaged in operating a portfolio of high-quality producing oil and natural gas assets, today reported financial and operating results for the three and twelve months ended December 31, 2023. FULL YEAR 2023 HIGHLIGHTSTotal daily production in 2023 averaged 1,711 Boe/d; oil production averaged 1,073 Bbl/d. Revenue totaled $32.3 million with oil sales of $28.4 million and natural gas and liquids sales of $4.0 million. Lease operating expense of $15.3 million, or $24.43 per Boe, a 8% and 9% decrease, respectively, from 2022. Oil and gas related capital expenditures of $3.4 million compared to $6.2 million in 2022. Generated Adjusted EBITDA, a non-GAAP measure, of $5.0 million for 2023. Ended...

Continue reading

Actelis Networks Reports Fiscal Full Year 2023 Results

FREMONT, Calif., March 26, 2024 (GLOBE NEWSWIRE) — Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, hybrid-fiber rapid deployment networking solutions for wide area IoT applications, today reported financial results for the fiscal full year 2023 ended December 31, 2023. Key Highlights:Strategic shift to IoT sales: Total revenue was $5.6 million for the full year 2023, compared to $8.8 million in the prior year. The Company nearly completed its strategic shift to IoT, with a proportional increase of IoT sales to 77% of annual sales, and further significant decline in Telecom revenue. A significant portion of the decline was a result of delays in on-going customer activities, which are expected to catch up in 2024. Direct margin increase: Gross Margin was 34% for the full year...

Continue reading

Nokia Corporation: Repurchase of own shares on 26.03.2024

Nokia CorporationStock Exchange Release26 March 2024 at 22:30 EET Nokia Corporation: Repurchase of own shares on 26.03.2024 Espoo, Finland – On 26 March 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 495,683 3.25CEUX – –BATE – –AQEU – –TQEX – –Total 495,683 3.25* Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.